2. Inflammation/Immunology

Inflammation/Immunology

Inflammation/Immunology

Related Products

PDF 93.1 MB

The diseases caused by disorders of the immune system fall into two broad categories: immunodeficiency and autoimmunity. Immunotherapy is also often used in the immunosuppressed (such as HIV patients) and people suffering from other immune deficiencies or autoimmune diseases. This includes regulating factors such as IL-2, IL-10, IFN-α. Infection with HIV is characterized not only by development of profound immunodeficiency but also by sustained inflammation and immune activation. Chronic inflammation as a critical driver of immune dysfunction, premature appearance of aging-related diseases, and immune deficiency.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-P991276
    FM-303 98%
    FM-303 is a monoclonal antibody inhibitor targeting interleukin-23 (IL-23). FM-303 is promising for research of immune system diseases and diseases of digestive system.
    FM-303
  • HY-P991277
    QX-004N 98%
    QX-004N (HS-20137) is a monoclonal antibody inhibitor targeting the p19 subunit of interleukin-23 (IL-23). QX-004N is promising for research of immune system diseases and diseases of digestive system.
    QX-004N
  • HY-P991279
    Mik-Beta-1 98%
    Mik-Beta-1 is a human IgG1-kappa anti-IL2RB monoclonal antibody. The isotype control of Mik-Beta-1 can be referenced to Human IgG1 kappa, Isotype Control (HY-P99001). Mik-Beta-1 can be used in research related to the prevention of allograft rejection.
    Mik-Beta-1
  • HY-P991280
    BMS-981164 98%
    BMS-981164 is a human IgG1-kappa anti-IL31 monoclonal antibody. The isotype control of BMS-981164 can be referenced to Human IgG1 kappa, Isotype Control (HY-P99001). BMS-981164 can be used in research related to atopic dermatitis.
    BMS-981164
  • HY-P991281
    REGN6490 98%
    REGN6490 is a humanized monoclonal anti-IL1RL2/IL-36R antibody. REGN6490 can be used in research related to pustular psoriasis.
    REGN6490
  • HY-P991283
    AMG-317 98%
    AMG 317 is a humanized monoclonal anti-CD124/IL4R/IL-4Rα antibody. Recommend Isotype Controls: Human IgG2 kappa, Isotype Control (HY-P99002). AMG 317 can be used in research related to asthma.
    AMG-317
  • HY-P991284
    QX-005N 98%
    QX 005N is a humanized monoclonal anti-CD124/IL4R/IL-4Rα antibody. QX 005N can be used in research related to asthma.
    QX-005N
  • HY-P991285
    MEDI-9314 98%
    MEDI-9314 is a humanized monoclonal anti-CD124/IL4R/IL-4Rα antibody. MEDI-9314 can be used in research related to skin allergy.
    MEDI-9314
  • HY-P991286
    FM101 98%
    FM101 is a humanized monoclonal anti-IL6 antibody. FM101 can be used in research related to asthma.
    FM101
  • HY-P991287
    FB704A 98%
    FB704A is a humanized monoclonal anti-IL6 antibody. FB704A can be used in research related to asthma.
    FB704A
  • HY-P991288
    OPR-003 98%
    OPR-003 is a human monoclonal antibody targeting IL-6. OPR-003 can be used in the research of Haematological malignancies and Rheumatoid arthritis.
    OPR-003
  • HY-P991289
    EBI-031 98%
    EBI-031 is a humanized antibody inhibitor targeting IL-6. EBI-031 is a nonsteroidal anti-inflammatory inhibitor. EBI-031 has superior biological efficacy in the management of ocular diseases, such as non-infectious uveitis (NIU) and retinal vascular diseases, and other disease including non-uveitic macular edema and diabetic macular edema.
    EBI-031
  • HY-P991290
    IRAB-B 98%
    IRAB-B is a human monoclonal antibody targeting INSR. IRAB-B is an insulin receptor (IR) antagonist and can be used in the study of insulin resistance and diabetes.
    IRAB-B
  • HY-P991313
    PD-360324 98%
    PD-360324 is a human monoclonal antibody (mAb) targeting CSF1/M-CSF. PD-360324 can be used in cutaneous lupus erythematosus, pulmonary sarcoidosis and rheumatoid arthritis research.
    PD-360324
  • HY-P991321
    ABT-110 98%
    ABT-110 is a human monoclonal antibody (mAb) targeting NGF/bNGF. ABT-110 reduces established thermal and mechanical hypersensitivity in the CFA rat model. ABT-110 can be used in persistent/chronic inflammatory pain research.
    ABT-110
  • HY-P991322
    Anti-NGF/bNGF Antibody (AS2886401-00)
    Anti-NGF/bNGF Antibody (AS2886401-00) is a human monoclonal antibody (mAb) targeting NGF/bNGF. Anti-NGF/bNGF Antibody (AS2886401-00) inhibits cytosolic Ca2+ influx. Anti-NGF/bNGF Antibody (AS2886401-00) produces a long-lasting analgesic effect on pain during exercise in a rat model of OA. Anti-NGF/bNGF Antibody (AS2886401-00) can be used in Osteoarthritis research.
    Anti-NGF/bNGF Antibody (AS2886401-00)
  • HY-P991323
    MEDI-1912 98%
    MEDI-1912 is a human monoclonal antibody (mAb) targeting NGF/bNGF. MEDI-1912 inhibits signaling through TrkA and p75 receptors. MEDI-1912 can be used in chronic pain research.
    MEDI-1912
  • HY-P991324
    MEDI-7352 98%
    MEDI-7352 is a human bispecific antibody (bsAb) targeting NGF/bNGF & TNF. MEDI-7352 can be used in osteoarthritis (OA) pain research.
    MEDI-7352
  • HY-P991325
    CRB-0089 98%
    CRB-0089 is a human monoclonal antibody (mAb) targeting NGF/bNGF. CRB-0089 can be used in analgesia research.
    CRB-0089
  • HY-P991333
    GSK-315234 98%
    GSK-315234 is a human IgG1 monoclonal antibody (mAb) targeting OSM . GSK-315234 can be used in the study of atherosclerosis Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).
    GSK-315234
Cat. No. Product Name / Synonyms Application Reactivity